ALXN - Alexion Pharmaceuticals Inc. (ALXN) CEO Ludwig Hantson on Q1 2019 Results - Earnings Call Transcript
Alexion Pharmaceuticals, Inc. (ALXN)
Q1 2019 Results Earnings Conference Call
April 25, 2019, 08:00 AM ET
Company Participants
Susan Altschuller - VP, IR
Ludwig Hantson - CEO & Director
Paul Clancy - EVP & CFO
John Orloff - EVP and Head, Research & Development
Brian Goff - EVP & Chief Commercial Officer
Conference Call Participants
Geoff Meacham - Barclays
Kennen MacKay - RBC Capital Markets
Geoffrey Porges - SVB Leerink
Paul Matteis - Stifel
Chris Raymond - Piper Jaffray
Phil Nadeau - Cowen and Company
Josh Schimmer - Evercore ISI
Matthew Harrison - Morgan Stanley